Taking into account the dual, both inhibiting and promoting, role of HIF-1a and Nrf2 transcription factors in cancer pathogenesis, as well as pleiotropic and context-dependent behavior of ascorbate, further research is needed to develop the strategies of its potential clinical use. This evidence concerns the gene NFE2L2 and cancer.